As of 2024-12-11, the Intrinsic Value of Boule Diagnostics AB (BOUL.ST) is
11.81 SEK. This BOUL.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 9.06 SEK, the upside of Boule Diagnostics AB is
30.30%.
The range of the Intrinsic Value is 8.04 - 19.25 SEK
11.81 SEK
Intrinsic Value
BOUL.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
8.04 - 19.25 |
11.81 |
30.3% |
| DCF (Growth 10y) |
9.56 - 21.40 |
13.55 |
49.6% |
| DCF (EBITDA 5y) |
4.41 - 9.06 |
6.14 |
-32.2% |
| DCF (EBITDA 10y) |
6.60 - 12.02 |
8.64 |
-4.6% |
| Fair Value |
-27.38 - -27.38 |
-27.38 |
-402.17% |
| P/E |
(71.29) - 20.84 |
(36.85) |
-506.7% |
| EV/EBITDA |
(34.22) - 10.38 |
(16.71) |
-284.5% |
| EPV |
10.44 - 17.61 |
14.03 |
54.8% |
| DDM - Stable |
(47.46) - (120.31) |
(83.88) |
-1025.9% |
| DDM - Multi |
6.67 - 13.62 |
9.00 |
-0.7% |
BOUL.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
351.83 |
| Beta |
-0.20 |
| Outstanding shares (mil) |
38.83 |
| Enterprise Value (mil) |
512.93 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.09% |
| Cost of Debt |
5.94% |
| WACC |
6.31% |